ArticleInternational journal of hematology2020

Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-label use in Japan.

Masayuki Kubo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.